Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Liabilities ₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr₹13,229 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹13,309 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr
Mar2020₹13,229 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr
6.35
Mar2020 ₹13,229 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,096.7 Cr 1.5% -9% 16% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,613.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 1.4% -1.1% -7.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.5%

-9%

16%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses